1985
DOI: 10.1021/bi00332a008
|View full text |Cite
|
Sign up to set email alerts
|

Rate of transmembrane electron transfer in chromaffin-vesicle ghosts

Abstract: The chromaffin vesicle of the adrenal medulla contains a transmembrane electron carrier that may provide reducing equivalents for dopamine beta-hydroxylase in vivo. This electron-transfer system can be assayed by trapping ascorbic acid inside resealed membrane vesicles (ghosts), adding an external electron acceptor such as ferricytochrome c or ferricyanide, and following the reduction of these acceptors spectrophotometrically. Cytochrome c reduction is more rapid at high pH and is proportional to the amount of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1986
1986
1998
1998

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 25 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…From a pharmacological point of view, the rapid oxygenation of PAESe by DBM with its associated ascorbate oxidation cycle could be of great interest. It is thought that the primary process for the regeneration of reduced ascorbate in adrenergic neurotransmitter vesicles is the semidehydroascorbate reductase/cyt B-561 system (Diliberto & Allen, 1981;Njus et al, 1982;Harnadek et al, 1985), which operates on the semidehydroascorbate produced from ascorbate during normal enzymatic turnover by DBM. Since we have demonstrated both qualitatively and quantitatively that no cyt c trappable semidehydroascorbate is produced during the nonenzymatic depletion of fully reduced ascorbate via PAESeO recycling, it is tempting to suggest that, if the electron equivalents for DBM arise solely from the recycling of vesicular semidehydroascorbate, the ASCH2 regenerating system would be incapable of preventing the PAESe-dependent depletion of vesicular ascorbate.…”
Section: Discussionmentioning
confidence: 99%
“…From a pharmacological point of view, the rapid oxygenation of PAESe by DBM with its associated ascorbate oxidation cycle could be of great interest. It is thought that the primary process for the regeneration of reduced ascorbate in adrenergic neurotransmitter vesicles is the semidehydroascorbate reductase/cyt B-561 system (Diliberto & Allen, 1981;Njus et al, 1982;Harnadek et al, 1985), which operates on the semidehydroascorbate produced from ascorbate during normal enzymatic turnover by DBM. Since we have demonstrated both qualitatively and quantitatively that no cyt c trappable semidehydroascorbate is produced during the nonenzymatic depletion of fully reduced ascorbate via PAESeO recycling, it is tempting to suggest that, if the electron equivalents for DBM arise solely from the recycling of vesicular semidehydroascorbate, the ASCH2 regenerating system would be incapable of preventing the PAESe-dependent depletion of vesicular ascorbate.…”
Section: Discussionmentioning
confidence: 99%
“…3), it reaches a steady state established by opposing transport and permeation processes. In these experiments, the pH gradient, monitored using acridine orange (14), was not affected by substrate addition over the range of substrate concentrations used here (data not shown). Consequently, we may analyze the transport/permeation steady state assuming a constant pH gradient.…”
Section: Fig 1 Summary Of Amine Fluxes In Chromaffin-vesicle Ghostsmentioning
confidence: 74%